A portfolio of mouse monoclonal antibodies raised against Influenza PR-8 has been developed at the University of Cambridge. The antibodies target the HA or NA epitopes of the virus.
These antibodies have been described in:
J Virol. 2013, 87(8), 4694–4703.
J Gen Virol. 2009, 90(Pt 11), 2592–2603.
Download further information here.
To find out more about how this website collects your personal data see www.enterprise.cam.ac.uk/about-us/information-compliance/data-protection/core-privacy-notices/website-users-use-personal-information/